Kallidin
 | |
| Names | |
|---|---|
| IUPAC name
L-lysyl-L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanyl-L-arginine | |
| Identifiers | |
342-10-9  | |
| 3D model (Jmol) | Interactive image |
| ChemSpider | 4470640 |
| ECHA InfoCard | 100.005.853 |
| 650 | |
| MeSH | Kallidin |
| PubChem | 5311111 |
| |
| |
| Properties | |
| C56H85N17O12 | |
| Molar mass | 1188.38 g/mol |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is  ?) | |
| Infobox references | |
Kallidin is a bioactive kinin formed in response to injury from kininogen precursors through the action of kallikreins.
Kallidin is a decapeptide whose sequence is H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH. It can be converted to bradykinin by the aminopeptidase enzyme.
It can be a substrate for carboxypeptidase M and N.[1]
Kallidin is identical to bradykinin with an additional lysine residue added at the N-terminal end and signals through the bradykinin receptor.
References
- ↑ Stefan Offermanns; Walter Rosenthal (2008). Encyclopedia of Molecular Pharmacology. Springer. pp. 673–. ISBN 978-3-540-38916-3. Retrieved 11 December 2010.
This article is issued from Wikipedia - version of the 10/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.